Health Technology · Pharmaceuticals: Major · NSE: TTKHLTCARE · data 2026-10-09
TTK Healthcare Limited
Health check: Average (5.9/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹1,016.6
Market cap
₹1,426 cr
P/E
19.4
P/B
—
ROE
6.0%
ROCE
2.1%
Debt / equity
0.02
Dividend yield
0.99%
1-year return
-13.7%
52-week high
₹1,247
52-week low
₹735
Operating margin
3.3%
Growth
| Revenue (last 12 months) | ₹888 cr |
| Net profit (last 12 months) | ₹74 cr |
| Sales growth, 3 years (yearly) | 5.7% |
| Profit growth, 3 years (yearly) | -53.2% |
Similar companies
Hester Biosciences Limited (HESTERBIO) · Accent Microcell Limited (ACCENTMIC) · Anlon Healthcare Limited (AHCL) · Bharat Parenterals Ltd. (BPLPHARMA) · Kopran Limited (KOPRAN)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open TTKHLTCARE in NSE Scanner →